ArticleNeurobiology of aging2016

Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer's disease clinical trials.

Joshua D Grill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.